Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion type Assertion NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_head.
- NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion description "[The position of the mutations and the loss of heterozygosity of MAP3K5 and MAP3K9 in 85% and 67% of melanoma samples, respectively, together suggest that the mutations are likely to be inactivating.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_provenance.
- NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion evidence source_evidence_curated NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_provenance.
- NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion SIO_000772 22197930 NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_provenance.
- NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion wasDerivedFrom ctd_human-20150221 NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_provenance.
- NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_assertion wasGeneratedBy ECO_0000218 NP21495.RArSkvTQqEVIa_KzKc0mpaRiAxFo-MZdfeZf09gcRyzkg130_provenance.